Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
47
datasets available to search
ShareScore release 0.9.0
Dataset results
47 results for “junction line”
Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer
ClinicalTrials.gov study NCT00183898. IPD Sharing: Not stated. Countries: 1. Publications: 0.
FOLFOX6 Versus mFOLFIRINOX as First Line Chemotherapy in Metastatic Gastric Cancer or Esophagogastric Junction Adenocarcinoma (Type II-III)
ClinicalTrials.gov study NCT04442984. IPD Sharing: NO. Countries: 1. Publications: 0.
The Efficacy and Safety of Iparomlimab/Tuvonralimab (Anti PD-1/CTLA-4) Combined With Albumin-bound Paclitaxel in Second-line Treatment of Patients With Advanced Gastric/Gastroesophageal Junction Adeno
ClinicalTrials.gov study NCT07139587. IPD Sharing: Not stated. Countries: 1. Publications: 0.
DV Combined With Cadonilimab in Subjects With HER2-expressing Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on First-line Therapy
ClinicalTrials.gov study NCT06221748. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fruquintinib Combined With Toripalimab and SOX Regimen in the First-line Treatment of Advanced Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
ClinicalTrials.gov study NCT05024812. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of The Second-line Treatment of Advanced Gastric / Gastroesophageal Junction Adenocarcinoma With Envafolimab and Lenvatinib Combined With Paclitaxel-albumin
ClinicalTrials.gov study NCT06030934. IPD Sharing: NO. Countries: 1. Publications: 0.
SHR-A1904 Compared With Investigator's Choice of Therapy in Claudin18.2 Positive Patitens With Second-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
ClinicalTrials.gov study NCT06649292. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of The Second-line Treatment of Advanced Gastric / Gastroesophageal Junction Adenocarcinoma With Cadonilimab and Fruquintinib Combined With Paclitaxel-albumin
ClinicalTrials.gov study NCT06406426. IPD Sharing: NO. Countries: 1. Publications: 0.
Bemarituzumab in FGFR2b+ Patients With Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction, Who Failed at Least One Prior Line of Palliative Chemotherapy
ClinicalTrials.gov study NCT06680622. IPD Sharing: NO. Countries: 1. Publications: 0.
To Evaluate the Efficacy of CT041 in Sequential Treatment After First-line Treatment of Advanced Gastric/Esophagogastric Junction Adenocarcinoma
ClinicalTrials.gov study NCT07179484. IPD Sharing: NO. Countries: 1. Publications: 0.
Second-Line Chemotherapy With Ramucirumab +/- Paclitaxel in Elderly Advanced Gastric or Gastroesophageal Junction Cancer Patients
ClinicalTrials.gov study NCT03760822. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
PD-1 Antibody + XELOX in 1st Line Serum A-fetoprotein (AFP)-Elevated Gastric or Gastroesophageal Junction Adenocarcinoma
ClinicalTrials.gov study NCT04098796. IPD Sharing: Not stated. Countries: 1. Publications: 0.
SHR-A1811 for Subjects With Her2-positive Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on or After First-line Anti-HER2 Therapy-containing Regimen
ClinicalTrials.gov study NCT06123494. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Efficacy and Safety of Panitumumab Combined With Docetaxel and Cisplatin as a First-line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
ClinicalTrials.gov study NCT01379807. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sintilimab and Nab-paclitaxel in Second-line Treatment of Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma
ClinicalTrials.gov study NCT04140318. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Phase 3 Study of Nimotuzumab and Irinotecan as Second Line With Advanced or Recurrect Gastric and Gastroesophageal Junction Cancer
ClinicalTrials.gov study NCT01813253. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Comparing Modified XELOX Plus Sintilimab With Standard XELOX Plus Sintilimab in First-line Treatment for HER2-negative Gastric/Gastroesophageal Junction Adenocarcinoma
ClinicalTrials.gov study NCT05918094. IPD Sharing: NO. Countries: 1. Publications: 0.
Taxanes or Platinum in Combination With Capecitabine Followed by Capecitabine Alone as First Line Treatment for Patients With Advanced Adenocarcinoma of Stomach or Esophagogastric Junction
ClinicalTrials.gov study NCT01468389. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fruquintinib Combined with Sintilimab As Second-line Therapy for Gastric or Gastro-esophageal Junction Adenocarcinoma
ClinicalTrials.gov study NCT05625737. IPD Sharing: NO. Countries: 1. Publications: 0.
First-line Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma With Dual Immunotherapy Combined With Chemotherapy
ClinicalTrials.gov study NCT07400315. IPD Sharing: NO. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.